Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients

NCT03671733 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Obesity

Interventions

DRUG: Liraglutide
DRUG: Exenatide
DRUG: Exenatide Microspheres for Injection

Sponsor

Xiangya Hospital of Central South University